Shanghai, China

Menglu Jiang

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Ge Precision Healthcare LLC. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cardiac Monitoring by Menglu Jiang

Introduction

Menglu Jiang is an accomplished inventor based in Shanghai, China. He has made significant contributions to the field of medical devices, particularly in the area of cardiac information presentation. His innovative approach aims to enhance the way cardiac data is visualized and interpreted for patients.

Latest Patents

Menglu Jiang holds a patent for a method related to medical devices that presents cardiac information for patients. The patent, titled "Medical devices and methods for presenting cardiac information for a patient," describes a method for collecting and displaying cardiac information from multiple leads connected to a patient. This method includes receiving the cardiac information, detecting segments within the data, and creating a radar chart that visually distinguishes data points from different sets of leads. This innovative visualization technique allows for better understanding and analysis of cardiac health.

Career Highlights

Menglu Jiang is currently associated with GE Precision Healthcare LLC, where he continues to work on advancing medical technologies. His expertise in cardiac monitoring and data presentation has positioned him as a valuable asset in the healthcare technology sector.

Collaborations

[Section skipped due to space constraints.]

Conclusion

Menglu Jiang's contributions to cardiac monitoring through his innovative patent demonstrate his commitment to improving patient care. His work at GE Precision Healthcare LLC continues to influence the medical device industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…